NewLimit Raises $130M to Reverse Aging
NewLimit develops therapies using epigenetic reprogramming, restoring human cells to a younger, healthier state.
Read More from the Global Wellness News ™
- Biggest AI opportunity in healthcare: wellness | Global survey finds young adults are really struggling | Blood pressure tech disruptor Aktiia raises $42M
- The latest must-have in the super-prime market? A ‘longevity room’